Literature DB >> 9628065

[Acute hepatic necrosis in a patient treated with cyproterone acetate].

A Lombardi1, P Ferrazza, F Castaldi, L Covotta, A Tesoriere, V Urbano, G Midiri.   

Abstract

The Authors report a case of prostatic carcinoma in a 84 year old male, treated with cyproterone acetate (CPA), complicated by a fatal fulminant hepatitis. He was admitted with a mixed jaundice followed by a derange of all liver function tests. Serological markers for hepatitis were negative. Ultrasonography and CT revealed no hepatic abnormality but gallstones and dilatation of principal bile duct with a terminal stricture. By the endoscopic retrograde cholangiography and sphincterotomy we put an external drain tube. He died 9 days after admission. Fatal hepatis due to CPA is a very rare complication but all patients on anti-androgenic drugs should have liver function closely monitored. CPA must be discontinued immediately at the first derange of liver function tests.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9628065

Source DB:  PubMed          Journal:  G Chir        ISSN: 0391-9005


  2 in total

1.  Hepatic failure induced by cyproterone acetate: A case report and literature review.

Authors:  Jae Heon Kim; Byung Wook Yoo; Won Jae Yang
Journal:  Can Urol Assoc J       Date:  2014-05       Impact factor: 1.862

Review 2.  Hepatotoxicity induced by cyproterone acetate: a report of three cases.

Authors:  Ioanna Savidou; Melanie Deutsch; Aspasia S Soultati; Dimitrios Koudouras; Georgia Kafiri; Spyridon P Dourakis
Journal:  World J Gastroenterol       Date:  2006-12-14       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.